Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Radiotherapy Provides Relief for Patients with Painful Heel Spurs

By HospiMedica International staff writers
Posted on 08 Aug 2012
Patients with plantar fasciitis experience substantially less pain and improved quality of life following a standard dose of external beam radiation therapy, a commonplace cancer treatment similar to receiving an X-ray, according to a randomized, cooperative group study.

The study’s findings were published online July 31, 2012, in the International Journal of Radiation Oncology-Biology-Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). More...
Approximately 8%-10% of the population has severe bone heel spurs, with the most common treatments for alleviating the pain being ice, heat, and various anti-inflammatory medications. Steroids and local anesthetics can be injected, and oral analgesic medications may be ordered, but most of these techniques have only provided short-term pain relief. The results of this study demonstrated that up to 80% of standard dose patients experienced complete pain relief, and pain relief remained constant or even improved for up to 64% of the study participants during the follow-up period of 48 weeks post-treatment.

“Severe plantar fasciitis is a chronic health issue, and it can be extremely painful--many of these men and women cannot walk or stand for a long time,” said Marcus Niewald, MD, PhD, a radiation oncologist at Saarland University Medical Center (Homburg/Saar, Germany), and one of the study’s authors. “Radiation therapy has been used for its anti-inflammatory effect for more than 60 years. We are extremely encouraged by the results of our research because evidence of improved quality of life for patients is clearly evident with the standard dose regimen.”

This study was a prospective, randomized trial of a total of 66 patients, with assessment every six weeks until 12-months post treatment. Four patients were secondarily excluded after the trial began; 29 patients received a standard dose regimen, and the remaining 33 patients received a low dose of radiation therapy. The standard dose patients were treated with a total dose of 6.0 Gy, applied in six single fractions of 1.0 Gy twice weekly on nonconsecutive days. The low dose arm received 0.6 Gy, applied in six single fractions of 0.1 Gy twice weekly on nonconsecutive days.

Related Links:

Saarland University Medical Center




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Critical Care Conversion Kit
Adapter+
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.